Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
52,988,211
Share change
+1,720,488
Total reported value
$1,917,110,562
Put/Call ratio
216%
Price per share
$36.18
Number of holders
169
Value change
+$57,678,654
Number of buys
102
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q2 2024

As of 30 Jun 2024, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,988,211 shares. The largest 10 holders included Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FMR LLC, Sofinnova Investments, Inc., VANGUARD GROUP INC, COMMODORE CAPITAL LP, STATE STREET CORP, Eversept Partners, LP, and Holocene Advisors, LP. This page lists 169 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.